1. Home
  2. IMNM vs PRO Comparison

IMNM vs PRO Comparison

Compare IMNM & PRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • PRO
  • Stock Information
  • Founded
  • IMNM 2006
  • PRO 1985
  • Country
  • IMNM United States
  • PRO United States
  • Employees
  • IMNM N/A
  • PRO N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • PRO EDP Services
  • Sector
  • IMNM Health Care
  • PRO Technology
  • Exchange
  • IMNM Nasdaq
  • PRO Nasdaq
  • Market Cap
  • IMNM 1.2B
  • PRO 1.1B
  • IPO Year
  • IMNM 2020
  • PRO 2007
  • Fundamental
  • Price
  • IMNM $18.12
  • PRO $23.14
  • Analyst Decision
  • IMNM Strong Buy
  • PRO Buy
  • Analyst Count
  • IMNM 8
  • PRO 7
  • Target Price
  • IMNM $25.75
  • PRO $24.54
  • AVG Volume (30 Days)
  • IMNM 1.4M
  • PRO 915.2K
  • Earning Date
  • IMNM 11-06-2025
  • PRO 10-27-2025
  • Dividend Yield
  • IMNM N/A
  • PRO N/A
  • EPS Growth
  • IMNM N/A
  • PRO N/A
  • EPS
  • IMNM N/A
  • PRO N/A
  • Revenue
  • IMNM $9,679,000.00
  • PRO $351,682,000.00
  • Revenue This Year
  • IMNM N/A
  • PRO $10.39
  • Revenue Next Year
  • IMNM $85.36
  • PRO $10.77
  • P/E Ratio
  • IMNM N/A
  • PRO N/A
  • Revenue Growth
  • IMNM N/A
  • PRO 8.92
  • 52 Week Low
  • IMNM $5.15
  • PRO $13.61
  • 52 Week High
  • IMNM $18.79
  • PRO $29.84
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 64.32
  • PRO 79.69
  • Support Level
  • IMNM $16.11
  • PRO $23.10
  • Resistance Level
  • IMNM $17.94
  • PRO $23.17
  • Average True Range (ATR)
  • IMNM 1.26
  • PRO 0.04
  • MACD
  • IMNM 0.02
  • PRO -0.13
  • Stochastic Oscillator
  • IMNM 86.56
  • PRO 80.56

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About PRO PROS Holdings Inc.

Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.

Share on Social Networks: